Drug Shortage Report for TEVA-GABAPENTIN
Report ID | 121506 |
Drug Identification Number | 02244514 |
Brand name | TEVA-GABAPENTIN |
Common or Proper name | GABAPENTIN 300MG CAP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 500's |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-07-29 |
Estimated end date | 2020-09-30 |
Actual end date | 2020-09-16 |
Shortage status | Resolved |
Updated date | 2020-09-17 |
Company comments | |
Health Canada comments | |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.